In Vitro Biotransformations of Tetrachloro(d,1-trans)-1,2-diaminocyclohexaneplatinum(IV) (Tetraplatin) in Rat Plasma

Cancer Research

Volumn 50, Issue 15, 1990, Pages 4539-4545

  Chaney, Stephen G ^a   Till, Gail Kaun ^a   Wyrick, Steven ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE; TETRAPLATIN;

ANIMAL CELL; ARTICLE; BIOTRANSFORMATION; BLOOD; CANCER CHEMOTHERAPY; DRUG METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT;

AMINO ACIDS; ANIMAL; ANTINEOPLASTIC AGENTS; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA; ORGANOPLATINUM COMPOUNDS; OXIDATION-REDUCTION; RADIOISOTOPE DILUTION TECHNIQUE; RATS; RATS, INBRED F344; SUPPORT, NON-U.S. GOV'T; TRITIUM;

EID: 0025291978     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Langford, C. H., and Gray, H. B. Ligand Substitution Processes. New York: W. A. Benjamin, 1965.
2. Blatter, E. E., Vollono, J. F., Krishman, B. S., and Dabrowiak, J. C. Interaction of the antitumor agents cis, cis, trans-PtIV (NH3)2Cl2(OH)2 and cis, cis, trans-PtIV l(CH3)2CHNH2]2Cl2(OH)2 and their reduction products with PM2 DNA. Biochemistry, 23:4817–4820,1984.
3. Gray, H. B. Rates of some substitution reactions of platinum(II) complexes. J. Am. Chem. Soc., 84:1548–1552, 1962.
4. Howe-Grant, M. E., and Lippard, S. J. Aqueous platinum(II) chemistry; binding to biological molecules. In: H. Siegel (ed.), Metal Ions in Biological Systems, Vol. 11: 63–125. New York: Marcell Dekker, 1980.
5. Johnson, N. P., Hoeschele, J. D., and Rahn, R. O. Kinetic analysis of the in vitro binding of radioactive cis- and trans-dichlorodiammineplatinum(II) to DNA. Chem.-Biol. Interact., 30: 151–169, 1980.
6. Butour, J. L., Mazard, A. M., and Macquet, J. P. Kinetics of the reaction of cis-platinum compounds with DNA in vitro. Biochem. Biophys. Res. Commun., 133: 347–353, 1985.
7. Cleare, M. J., and Hoeschele, J. D. Studies on the antitumor activity of Group VIII transition metal complexes. Part I. Platinum(II) complexes. Bioinorg. Chem., 2: 187–210, 1973.
8. Pendyala, L., Cowens, J. W., Chheda, G. B., Dutta, S. P., and Creaven, P. J. Identification of cis-dichloro-bis-isopropylamine platinum(II) as a major metabolite of iproplatin in humans. Cancer Res., 48: 3533–3536,1988.
9. Pendyala, L., Krishnan, B. S., Walsh, J. R., Arakali, A. V., Cowens, J. W., and Creaven, P. J. Studies on the human metabolism of iproplatin. Cancer Chemother. Pharmacol., 25: 10–21, 1989.
10. Daley-Yates, P. T., and McBrien, D. C. H. Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumor activity of cisplatin. Biochem. Pharmacol., 33:3063–3070,1984.
11. Mistry, P., Lee, C., and McBrien, D. C. H. Intracellular metabolites of cisplatin in the rat kidney. Cancer Chemother.Pharmacol., 24:73–79, 1989.
12. Elferink, F., van der Vijgh, W. J. F., and Pinedo, H. M. Analysis of antitumor [1,1-bis(aminomethyl)cyclohexane]platinum(II) complexes derived from spi-roplatin by high-performance liquid chromatography with differential pulse amperometric detection. J. Chromatogr., 320:379–392, 1985.
13. Long, D. F., and Repta, A. J. Cisplatin: chemistry, distribution, and biotransformation. Pharm. Drug Dispos., 2: 1–16, 1981.
14. van der Veer, J. L., Peters, A. R., and Reedijk, J. Reaction products from platinum(IV) amine compounds and 5'-GMP are mainly bis(5-GMP)-platinum(II) amine adducts. J. Inorg. Biochem., 26:137–142,1986.
15. Elferink, F., van der Vijgh, W. J. F., van der Poort, S. E. J. M., Henzen-Logmans, S. C., and Pinedo, H. M. Influence of hydrolysis products of aqua(1,1-bis(aminomethyl)cyclohexane)sulfatoplatinum(II) on toxicity in rats. Cancer Lett., 25:61–69, 1984.
16. Burchenal, J. H., Kalaher, K., Dew, K., and Lokys, L. Rationale for the development of platinum analogs. Cancer Treat. Rep., 63:1493–1498,1979.
17. Behrens, B. C., Hamilton, T. C., Masuda, H., Grotzinger, K. R., Whang-Peng, J., Louie, K. G., Knutsen, T., McKay, W. M., Young, R. C., and Ozols, R. F. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogs. Cancer Res., 47:414–418, 1987.
18. Hills, C. A., Kelland, L. R., Able, G., Siracky, J., Wilson, A. P., and Harrap, K. R. Biological properties of ten ovarian carcinoma cell lines: calibration in vitro against four platinum complexes. Br. J. Cancer, 59:527–534, 1988.
19. Smith, J. H., Smith, M. A., Litterst, C. L., Copley, M. P., Uozumi, J., and Boyd, M. R. Comparative toxicity and renal distribution of the platinum analogs tetraplatin, CHIP, and cisplatin at equimolar doses in the Fischer 344 rat. Fundam. Appl. Toxicol., 10:45–61, 1988.
20. Smith, M. A., Smith, J. H., Litterst, C. L., Copley, M. P., Uozumi, J., and Boyd, M. R. In vivo biochemical indices of nephrotoxicity of platinum analogs tetraplatin, CHIP, and cisplatin in the Fischer 344 rat. Fundam. Appl. Toxicol., 70:62–72, 1988.
21. Anderson, W. K., Quagliato, D. A., Haugwitz, R. D., Narayanan, V. L., and Wolpert-DeFilippes, M. K. Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane. Cancer Treat. Rep., 70:997–1002, 1986.
22. Wilkoff, L. J., Dulmadge, E. A., Trader, M. W., Harrison, S. D., and Griswold, D. P. Evaluation of transtetrachloro-l,2-diaminocyclohexaneplatinum(IV) in murine leukemia LI210 resistant and sensitive to cis-diam-minedichloroplatinum(II). Cancer Chemother. Pharmacol., 20: 96–100, 1987.
23. Rahman, A., Roh, K. J., Wolpert-DeFilippes, M. K., Goldin, A., Venditta, J. M., and Woolley, P. V. Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexaneplatinum(IV), a new platinum analogue. Cancer Res., 48:1745–1752, 1988.
24. Mauldin, S. K., Richard, F. A., Plescia, M., Wyrick, S. D., Sancar, A., and Chaney, S. G. High performance liquid chromatographic separation of platinum complexes containing the 1,2-diaminocyclohexane carrier ligand. Anal. Biochem., 157:129–143, 1986.
25. Gibbons, G. R., Wyrick, S., and Chaney, S. G. Rapid reduction of tetrachloro(d,l-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in RPMI-1640 tissue culture medium. Cancer Res., 49:1402–1407, 1989.
26. Mauldin, S. K., Plescia, M., Richard, F. A., Wyrick, S. D., Voyksner, R. D., and Chaney, S. G. Displacement of the bidentate malonate ligand from (d,l-trans-l,2-diaminocyclohexane)malonatoplatinum(II) by physiologically important compounds in vitro. Biochem. Pharmacol., 37: 3321–3333, 1988.
27. Mauldin, S. K., Gibbons, G., Wyrick, S. D., and Chaney, S. G. Intracellular biotransformation of platinum compounds with the 1,2-diaminocyclohexane carrier ligand in the L1210 cell line. Cancer Res., 48:5136–5144, 1988.
28. Wyrick, S. D., and Chaney, S. G. Tritiated platinum antitumor agents containing the trans-(d,l)- 1,2-diaminocyclohexane carrier ligand. J. Labelled Cmpd. Radiopharm., 25: 349–357, 1988.
29. Wyrick, S. D., and Chaney, S. G. Synthesis of [,95mPtJtetraplatin. J. Labelled Cmpd. Radiopharm., in press, 1990.
30. Ellman, G. L. Tissue sulfhydryl groups. Arch. Biochem. Biophys., 82: 70–77, 1959.
31. van Caneghem, P. Modification of the concentration of plasma thiols and disulfide groups after irradiation. C R Soc. Biol. (Paris), 162:792–794,1968.
32. Gonias, S. L., and Pizzo, S. V. Complexes of serum albumin and cis-diamminedichloroplatinum(II). J. Biol. Chem., 258: 5764–5769, 1983.
33. Dittmer, D. S. Blood and Other Body Fluids. Washington, DC: Federation of American Societies for Experimental Biology, 1961.
34. LeRoy, A. F., and Thompson, W. C. Binding kinetics of tetrachloro-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) and cis-diammine-dichloro-platinum(II) at 37° with human plasma proteins and with bovine serum albumin. Does aquation precede protein binding? J. Natl. Cancer Inst., 81: 427–436, 1989.
35. Daley-Yates, P. T., and McBrien, D. C. H. The inhibition of renal ATPase by cisplatin and some biotransformation products. Chem.-Biol. Interact., 40: 325–334, 1982.
36. Alden, W. W., and Repta, A. J. Exacerbation of cisplatin-induced nephrotoxicity by methionine. Chem.-Biol. Interact., 48:121–124, 1984.
37. Speer, R. J., Ridgway, M., Hall, L. M., and Stewart, D. P. Preclinical testing of some cisplatin congeners as potential antitumor agents. J. Clin. Hematol. Oncol., 70:9–13, 1980.
38. Balazova, E., Hrubiska, M., and Ujhazy, V. Comparison of the effectivity of two diaminocyclohexane Pt-complexes. Neoplasma (Bratisl.), 32: 537–541, 1985.